Mental Disorders

The supplied grounding does not support a single cause or aetiology for mental disorders as a whole. It indicates that psychiatric disorders are complex and may be studied through genetic underpinnings, including candidate genes, gene regions, and single-nucleotide polymorphisms, but it does not establish a unified cause. It also notes that mental disorders are examined in relation to microbiology and the gastrointestinal microbiome, but without specifying causal relationships.

The grounding supports a view of mental disorders as complex neuropsychiatric conditions with underlying components that can be decomposed into endophenotypes. These endophenotypes may be neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive, or neuropsychological, and are used to study pathways between genotype and the clinical syndrome. The literature also references physiopathology, brain-behavior relationships, and brain-gut axis research, but does not provide a single disease mechanism.

The grounding supports age-related epidemiology, with many mental disorders beginning in childhood, adolescence, or early adulthood. It also indicates that stigma can deter help-seeking, which may worsen recognition and care, but it is not presented as a biological risk factor. Genetic variation is discussed as relevant to susceptibility, but specific risk factors are not established in the supplied material.

The supplied grounding supports treatment at the modality level rather than for any one disorder subtype. It includes psychotherapy, mental health services, drug therapy, and non-invasive electrical and magnetic brain stimulation as therapeutic approaches studied in psychiatric disorders. It also mentions research on cannabinoids, cannabidiol, ketamine, psilocybin, lysergic acid diethylamide, tryptophan, and dopamine, but does not establish these as standard care across mental disorders.